Novel non-steroidal compounds are provided which are useful in treating diseases or disorders associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-KB activity, including metabolic and inflammatory and immune diseases or disorders, having the structure of formula (I): an enantiomer, diastereomer, or tautomer thereof, or a pharmaceutically-acceptable salt thereof, in which the variables are as defined in the specification.
提供了一种新型的非类
固醇化合物,可用于治疗与糖皮质激素受体、AP-1和/或NF-KB活性调节相关的疾病或紊乱,包括代谢性、炎症性和免疫性疾病或紊乱,其结构如下式(I):其对映体、二对映体或互变异构体,或其药用可接受盐,其中变量如规范中所定义。